High Schooler (Rakshith Srinivasan) Empowers Youth with Nonprofit “Unlimited Potential”, Raises $100,000 for Sports Medicine Research and Advocacy

Research indicates that approximately 3.5 million children under the age of 14 in North America do not participate in sports due to physical disabilities, genetic disorders, or other chronic health conditions. Unlimited Potential envisions a world where children facing challenges have the tools to overcome them, fostering an inclusive environment where everyone can participate in school sports.

Rakshith Srinivasan, a driven high school student from Eastside Preparatory School, Kirkland, WA, has founded a nonprofit organization called Unlimited Potential (UP). UP is dedicated to generating awareness and fundraising for sports medicine research, aiming to empower children with physical disabilities and chronic health conditions to participate in school sports with ease. Rakshith Srinivasan’s passion for sports medicine research and STEM awareness has led him to create UP and make a difference in the lives of young athletes within the community.

Unlimited Potential focuses on collaborating with sports medicine researchers, sports medicine research labs, orthopedic doctors and universities to raise awareness about groundbreaking research and to secure funds for hospitals and labs across North America.

The organization supports research initiatives that have resulted in significant breakthroughs such as prosthetics, bionics, stem cell therapies, CAR-T cell therapies, and other innovative treatments, maximizing their affordability and availability.

Our mission at Unlimited Potential is to generate awareness within our communities about game-changing research in sports medicine and to raise funds for researchers and doctors working on complex medical problems. We believe accelerating research, and enabling affordability should ultimately lead to enabling our vision of – No Wheel Chairs by 2050″! said Rakshith Srinivasan, the founder of Unlimited Potential.

UP operates as a network of passionate high school students who are actively engaged in sports and have a keen interest in science and research. These student volunteers collaborate with doctors and medical researchers from renowned organizations such as Seattle Children’s, Fred Hutch Cancer Center, Special Olympics of Washington and the University of Washington’s Institute of Sports Medicine. Through these partnerships, the volunteers gain insights into the research, understand its impact, and actively contribute to fundraising efforts.

Unlimited Potential Sarcoma Bone Cancer Research
UP volunteers distribute funds for Sarcoma Bone cancer research with Fred Hutcheson Cancer Centre in Seattle Washington (March 2023)

Since its establishment in 2020, Unlimited Potential has achieved significant milestones. With ten full-time volunteers and over 600 part-time volunteers across North America, the organization has made substantial strides in advocating for sports medicine research within local communities. These efforts have resulted in the cultivation of over 500 grassroots donors. Contributions from these donors have supported eight research programs in areas such as prosthetics, bionics, muscular dystrophy, skeletal dysplasia, limb deformities, bone cancer, athlete mental health, and human-centered design.

Since its inception, UP campaigns played a pivotal role in raising $100,000 for research through community donors in their respective school districts. The funds were subsequently presented to researchers at labs such as Seattle Children’s Orthopedic Research Lab and Fred Hutchinson Cancer Center to name a few.

Team Unlimited Potential has assembled a dedicated advisory board of like-minded leaders who mentor the volunteers. This advisory team assists in research selection, donor discussions, campaign planning, fundraising activities, and facilitates introductions to researchers and doctors.

UP’s founder, Rakshith Srinivasan has written a book, “Overcoming Obstacles” which details the cutting-edge research happening in the field of sports science and research. The sales from the book will 100% go to the fundraising campaigns conducted by Unlimited Potential

Overcoming Obstacles“, can be purchase in online version or paperback from Barns and NobleRakuten KoboGoodreads and Amazon.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”